Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Pharma

Synthetic mRNA Production Landscape Assessment

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

View

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Diagnostics

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

View

Voice-of-Customer Research

Life Science Tools & Manufacturing

Multi-Omic Technology Opportunity Assessment

A ~$100M research tools and diagnostics company wanted to understand key applications and revenue potential of its novel technology to inform a go / no-go development decision

View

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

Pharma

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to the recent approval of a competing cancer therapy in earlier lines of treatment

View

Competitive Analysis

Voice-of-Customer Research

Diagnostics

Longitudinal Monitoring of Cancer Early Detection Market

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

View

Competitive Analysis

Diagnostics

Diagnostic Advisory Board

A diagnostics company asked DeciBio to convene an advisory board (ad board) to help it position its relatively new somatic oncology genomic profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

AdBoards

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch